Treatment stores

Nanotherapy for the treatment of hepatocellular carcinoma

Newswise – Nanotherapies have shed new light on the treatment of HCC by allowing site-specific in vivo delivery of chemotherapeutics specifically to neoplastic hepatocytes without affecting normal hepatocytes. Thus, nanotherapies have shown tremendous potential and there is tremendous momentum for rapid translation from the preclinical to the clinical domain to significantly prolong survival in HCC. In Nanotherapeutics for the Treatment of Hepatocellular Carcinoma, authoritative experts in the field explored important aspects of nanotherapy for HCC. The book comprehensively, vividly and explicitly describes the molecular pathogenesis, diagnostic aspects and nanotherapy of HCC, while highlighting the challenges of conventional therapy and the benefits of nanotherapy. The book’s chapters also cover recent investigations of HCC nanotherapies, types of nanomedicines, recent patents, commercially available nanotherapies, and future perspective to give readers a comprehensive review of the topic. In addition to these defining characteristics, the book provides several references for further reading. The book is an ideal resource on HCC nanotherapy for postgraduate medical and pharmacology students, faculty, researchers and biomedical scientists working on HCC and nanotherapy.

About the editor

Biswajit Mukherjee, Ph.D., WBCS, FIC, FICS, is Professor and former Head of Department of Pharmaceutical Technology, Jadavpur University, Kolkata and former Professor, Graduate Institute of Pharmaceutical Sciences, Panjab University, Chandigarh in India. He is a former member of DAAD (German Academic Exchange Services) and Visiting Researcher, German Cancer Research Center (DKFZ), Heidelberg. He was a Visiting Scholar at the University of London School of Pharmacy and an Indo-Hungarian Educational Exchange Fellow at the National Research Institute for Radiobiology and Radiohygiene in Budapest. He works on antisense technology, nanomedicine and targeted drug delivery on pharmacokinetics and pharmacodynamics. He works on antisense technology, cancer chemoprevention, nanodrug carriers, nanomedicine and targeted drug delivery systems, with a particular focus on biopharmaceuticals, pharmacokinetics and pharmacodynamic studies. He has over 150 publications in reputable international journals and has written numerous book chapters in the field. He is the Executive Secretary of the Indian Association of Pharmaceutical Scientists and Technologists. He is a recipient of Oversees Biotechnology Research Associateship 2005 (Department of Biotechnology, Govt. of India), 2009 Research Award from University Grants Commission (India) and Association of Pharmaceutical Teachers of India -Professor CJ Shisoo in 2016 for research in pharmaceutical sciences. .